Cancer: Medical Treatments

Department of Health and Social Care written question – answered on 20th August 2020.

Alert me about debates like this

Photo of Alex Norris Alex Norris Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the availability of (a) radioligand therapy and (b) short shelf-life medicines after the end of the transition period.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

Holding answer received on 21 July 2020

The United Kingdom’s published approach sets out how we want to facilitate trade in medicinal products, including radioligand therapy and short shelf-life medicines, to support high levels of patient safety.

We will continue to work closely with the pharmaceutical industry, the National Health Service and others in the supply chain to help ensure patients can access the medicines they need, and that precautions are in place to reduce the likelihood of future shortages.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.